Banner
News header

12th November 2021

Cumulus’ CSO appears at FT Pharma conference to discuss new dementia treatments

14th September 2021

Cumulus Neuroscience Appoints Dr Ruth McKernan CBE as Chair

17th June 2021

Cumulus Neuroscience Appoints Dr Ian Campbell to Board of Directors

4th May 2021

Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund

5th April 2021

Cumulus Neuroscience receives £1.8m Biomedical Catalyst grant to expand CNS biomarker platform

1st March 2021

Cumulus Neuroscience adds Winterlight Labs’ speech analytics technology to its integrated physiological and digital biomarker platform for CNS disorders

5th January 2021

Cumulus Neuroscience licences P1vital Product’s facial expression recognition software for use in CNS trials